© Reuters.
By Sam Boughedda
Investing.com — Shares of direct-to-consumer healthcare apparel and lifestyle brand Figs Inc (NYSE:) have plummeted 22% in extended trading after the company cut its 2022 revenue forecast.
Figs also missed top and bottom-line estimates, posting per share of $0.05 on revenue of $110.1 million. Analysts polled by Investing.com expected earnings per share of $0.06 on revenue of $117.13 million. Revenue increased 26.4% year over year, driven by higher average order values and strength in lifestyle products.
At the end of the first quarter, active customers had increased 31.1% to 2 million, while net revenues per active customer rose 6.1% year over year to $226. In addition, the company said that the average order value was $116, an increase of 16% year over year, driven by a higher mix of lifestyle products.
Looking ahead, Figs said it sees revenue for 2022 between $510 million to $530 million, down on the previous outlook of $550 million to $560 million. Figs stated the lower revenue guidance reflects supply chain challenges and broader macroeconomic factors, including high inflation and shifts in consumer spending patterns.
“We are well positioned to fuel profitable growth for the years to come due to our strong foundation, recession resistant industry and deep understanding of the healthcare community,” said Figs Co-CEO and Co-Founder, Trina Spear.
Be the first to comment